Everolimus in Pancreatic Neuroendocrine Carcinomas G3
Sign Up to like & getrecommendations! Published in 2017 at "Pancreas"
DOI: 10.1097/mpa.0000000000000762
Abstract: Objective The aim of this study was to investigate everolimus efficacy in well-moderately differentiated pancreatic NEC (pNEC) G3. Methods This was a retrospective analysis of patients with pNEC G3 and Ki67 20% to 55% treated… read more here.
Keywords: neuroendocrine carcinomas; pancreatic neuroendocrine; survival months; oncology ... See more keywords